Gilles Bignan
24Patents
4h-index
71Co-inventors
62Inventor score
Filing activity: Sep 5, 2003 → Nov 8, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8685990B2 | Pyrimidine compounds as delta opioid receptor modulators | Chemistry; Metallurgy | 19 | Active |
| US7579356B2 | Thia-tetraazaacenaphthylene kinase inhibitors | Human Necessities | 9 | Expired |
| US10077261B2 | Imidazolin-5-one derivative useful as FASN inhibitors for the treatment of cancer | Chemistry; Metallurgy | 7 | Active |
| US7081463B2 | Hydroxy alkyl substituted 1,3,8-Triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1receptor mediated disorders | Human Necessities | 5 | Expired |
| US7655670B2 | 3-spirocyclic indolyl derivatives useful as ORL-1 receptor modulators | Human Necessities | 3 | Active |
| US8445690B2 | Aminothiazolones as estrogen related receptor-alpha modulators | Chemistry; Metallurgy | 3 | Active |
| US7582649B2 | Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders | Human Necessities | 3 | Active |
| US8153791B2 | Substituted pyrimidinyl oxime kinase inhibitors | Chemistry; Metallurgy | 2 | Active |
| US8796256B2 | Substituted thiazolidinedione indazoles, indoles and benzotriazoles as estrogen-related receptor-α modulators | Human Necessities | 1 | Active |
| US8778956B2 | Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders | Human Necessities | 1 | Active |
| US8263781B2 | Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators | Chemistry; Metallurgy | 1 | Active |
| US10501469B2 | Substituted thiohydantoin derivatives as androgen receptor antagonists | Chemistry; Metallurgy | 1 | Active |
| US8513271B2 | Pyrimidine compounds as delta opioid receptor modulators | Chemistry; Metallurgy | 0 | Active |
| US11597746B2 | Cyclic dinucleotides as sting agonists | Chemistry; Metallurgy | 0 | Active |
| US8399681B2 | Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators | Chemistry; Metallurgy | 0 | Active |
| US10000502B2 | Substituted thiohydantoin derivatives as androgen receptor antagonists | Chemistry; Metallurgy | 0 | Active |
| US8741916B2 | 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the ORL-1 receptor | Human Necessities | 0 | Active |
| US8580832B2 | Substituted phenoxy aminothiazolones as estrogen related receptor-α modulators | Human Necessities | 0 | Active |
| US8426604B2 | Aminothiazolones as estrogen related receptor-alpha modulators | Chemistry; Metallurgy | 0 | Active |
| US11472830B2 | Cyclic dinucleotides as sting agonists | Human Necessities | 0 | Active |
| US11021511B2 | Cyclic dinucleotides as sting agonists | Human Necessities | 0 | Active |
| US11492367B2 | Cyclic dinucleotides as sting agonists | Human Necessities | 0 | Active |
| US8367825B2 | Substituted pyrimidinyl oxime kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10981926B2 | Substituted thiohydantoin derivatives as androgen receptor antagonists | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.